WEBINAR

Applying the Lessons of the Pandemic to Your Upcoming Trial

A Free CenterWatch Webinar  |  Sponsored by PCM Trials

Hybrid and decentralized clinical trials (DCT) broaden trial access so that you can reach a larger more diverse pool of patients. This free webinar will show you how.

While the COVID-19 pandemic increased the number of hybrid and DCTs, the clear benefits mean there’s no going back. There’s a 93% increase in clinical trials with a virtual and/or decentralized component beginning in 2022, over those in 2020

Traditional clinical trials are slower, more expensive and less efficient than DCTs and tend to limit participation by placing time and financial barriers on potential patients. Plus, they reduce diversity

As patient-centricity has become a necessity, exclusively site-based trials will become increasingly problematic. By adding DCT techniques, you’ll solve many of the issues, especially given the FDA’s pressure to improve clinical trial diversity. When DCT methods are introduced during protocol development, you can recruit more diverse participants from wider geographic areas

Ellen Weiss — PCM Trials’ vice president, in-home solutions, decentralized clinical trials — will explain the positive effects hybrid and DCT methods have on clinical trials now and into the future, helping you fully realize the advantages for your trials.

Webinar Takeaways:

• Clinical trial-related lessons learned from the COVID-19 pandemic
• Which are the most-requested and most-used activities in home visit programs today
• How to realize the benefits of decentralized clinical trials going forward
• The role of home-based nursing in clinical trials
• The timelines and processes a quality provider should deliver

Improve clinical trial enrollment, retention and diversity by integrating hybrid and DCT methods into your protocols. Join us by registering for this free webinar today.

Who Will Benefit:

• Pharmaceutical and biotech companies
• CROs
• Sponsors
• Clinical researchers
• Academic medical center teams
• Research and development leadership
• Clinical trial executives
• Clinical research and development leadership
• Compliance officers
• Medical research executives
• Global medical affairs staff

Meet Your Presenter:

Ellen Weiss
Vice President, In-Home Solutions, Decentralized Clinical Trials
PCM Trials

Ellen Weiss is vice president, in-home solutions, decentralized clinical trials at PCM Trials. She is an expert in connecting CROs and sponsors with right-sized hybrid and remote solutions to collect complete data. She has spoken on understanding the logistical support necessary for investigational medicinal product (IMP) delivery and sample collection, IMP dosing and sampling considerations, logistic options and best-use cases. Ms. Weiss has deep knowledge of clinical trial research nurses and the services they provide, which enables sponsors, CROs and site investigators to have confidence that alternate-site visits can be carried out with the same data quality and subject safety as onsite visits across all therapeutic areas. She is a member of the Healthcare Businesswomen’s Association and a volunteer for the American Society of Clinical Oncology.